Amphetamine-Related Fatalities and Altered Brain Chemicals: A Preliminary Investigation Using the Comparative Toxicogenomic Database
Molecules · 15.06.2023 · 28 (12) · 4787
DOI: 10.3390/molecules28124787 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 15.06.2023. Verfasst von Murad Tumayhi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia. Hauptthemen laut MEDLINE: Amphetamine, Fatty Acids, Omega-3. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia, Deanship of Scientific Research, Jazan University.
Abstract (Originalsprache)
Amphetamine is a psychostimulant drug with a high risk of toxicity and death when misused. Abuse of amphetamines is associated with an altered organic profile, which includes omega fatty acids. Low omega fatty acid levels are linked to mental disorders. Using the Comparative Toxicogenomic Database (CTD), we investigated the chemical profile of the brain in amphetamine-related fatalities and the possibility of neurotoxicity. We classified amphetamine cases as low (0–0.5 g/mL), medium (>0.5 to 1.5 g/mL), and high (>1.5 g/mL), based on amphetamine levels in brain samples. All three groups shared 1-octadecene, 1-tridecene, 2,4-di-tert-butylphenol, arachidonic acid (AA), docosahexaenoic acid (DHA), eicosane, and oleylamide. We identified chemical–disease associations using the CTD tools and predicted an association between DHA, AA and curated conditions like autistic disorder, disorders related to cocaine, Alzheimer’s disease, and cognitive dysfunction. An amphetamine challenge may cause neurotoxicity in the human brain due to a decrease in omega-3 fatty acids and an increase in oxidative products. Therefore, in cases of amphetamine toxicity, a supplement therapy may be needed to prevent omega-3 fatty acid deficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology & Toxicology, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
- Forensic Toxicology Services, Forensic Medical Center, Ministry of Health, Jazan 45142, Saudi Arabia.
- Pharmacy Practice Research Unit, Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
- Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
ORCID-Profile: Saeed Alshahrani, Saad S Alqahtani, Ibraheem Attafi
Förderung
- The Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia
- Deanship of Scientific Research, Jazan University
Zitieren
APA
Tumayhi, M., Banji, D., Khardali, I., Banji, O. J. F., Alshahrani, S., Alqahtani, S. S., Muqri, S., Abdullah, A., Sherwani, W., & Attafi, I. (2023). Amphetamine-Related Fatalities and Altered Brain Chemicals: A Preliminary Investigation Using the Comparative Toxicogenomic Database. Molecules, 28(12), 4787. https://doi.org/10.3390/molecules28124787
Vancouver
Tumayhi M, Banji D, Khardali I, Banji OJF, Alshahrani S, Alqahtani SS, et al. Amphetamine-Related Fatalities and Altered Brain Chemicals: A Preliminary Investigation Using the Comparative Toxicogenomic Database. Molecules. 2023;28(12):4787. doi:10.3390/molecules28124787
BibTeX
@article{Tumayhi2023,
author = {Tumayhi, Murad and Banji, David and Khardali, Ibrahim and Banji, Otilia J F and Alshahrani, Saeed and Alqahtani, Saad S and Muqri, Safiah and Abdullah, Amal and Sherwani, Wedad and Attafi, Ibraheem},
title = {Amphetamine-Related Fatalities and Altered Brain Chemicals: A Preliminary Investigation Using the Comparative Toxicogenomic Database},
journal = {Molecules},
year = {2023},
volume = {28},
number = {12},
pages = {4787},
doi = {10.3390/molecules28124787}
}
EUVIMED